To investigate the optimal timepoint of replanning during a curative radio(chemo)therapy in patients with Head and Neck cancer. Furthermore we like to analyze if the optimal timepoint of replanning is depending on tumorlocation, tumor volume or…
ID
Source
Brief title
Condition
- Miscellaneous and site unspecified neoplasms malignant and unspecified
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
To investigate the optimal moment of replanning during a curative
radio(chemo)therapy treatment in patients with a head and neck tumor
Secondary outcome
Analyse if the optimal moment of replanning is depending on tumor location,
tumor volume or absolute dose at the OAR
Background summary
During the 6-7 weeks of irradiation the tumor and surrounding organs at risk
change in shape and volume. Recent studies show that when the treatment was
adapted to these changes by using "Adaptive Radiotherapy", the therapeutic
ratio increased, particularly for the parotid glands. With this technique a new
plan is made at the end of the second week of the irradiation. Repeat scan in
the second week is based on a study by Van Kranen and published data which
showed a 10% decrease of the parotid glands volume. Unknown is if the second
week is the optimal timepoint for replanning. We like to investigate if the
second week is the right timepoint for replanning versus the third and fourth
week. Furthermore we like to analyse if the optimal moment of replanning is
depending on the location of the tumor, tumor volume or the absolute dose in
the organs at risk.
Study objective
To investigate the optimal timepoint of replanning during a curative
radio(chemo)therapy in patients with Head and Neck cancer. Furthermore we like
to analyze if the optimal timepoint of replanning is depending on
tumorlocation, tumor volume or absolute dose in OaR.
Study design
Prospective study with 50 patients
Intervention
Twice an extra CT scan without contrast
Study burden and risks
Twice an extra CT scan without contrast will be done; it will take an extra 30
minutes but there's hardly any risk and no extra hospital visits.
Radiation exposure per scan is 10mSv and negligible compared to the
radiotherapy treatment
Plesmanlaan 121
1066CX AMSTERDAM
NL
Plesmanlaan 121
1066CX AMSTERDAM
NL
Listed location countries
Age
Inclusion criteria
- Signed written Informed Consent
- Squamouscell carcinoma in oral cavity, oropharynx, nasopharynx, larynx or hypopharynx
- adaptive radiotherapy or radiochemotherapy as primairy treatment
Exclusion criteria
- < 18 years old
- pregnancy
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL38171.031.11 |